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Trypanosoma evansi, known as an animal trypanosome, is widely distributed in many countries of Africa,
Asia and South America; it causes signiﬁcant economic loss in these countries. A few cases have also
occurred in some countries of Europe due to the importation of infected animals from endemic regions.
Rare human T. evansi infections were attended by the health departments and international health or-
ganizations in these endemic countries. Trypanosoma lewisi, a cosmopolitan parasite of rats, sometimes
found in humans, is currently considered as a zoonotic pathogen and has gained special attention from
scientists and international health organizations such as the World Health Organization. The current
study considered the serological screening of human infection by T. evansi and T. lewisi in a Chinese
human population. None of the 622 samples was found positive for T. evansi infection using the card
agglutination test for the trypanosome antigen Rotat 1.2, while, 2.41% of the examined serum samples
exhibited some seropositivity to T. lewisi using enzyme-linked immunosorbent assay. No signiﬁcant
difference was found between the samples from areas in the South (Zhaoqing, Guangdong) and Central
(Zhengzhou, Henan) China.
Copyright © 2018, Kasetsart University. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Trypanosoma evansi, a Trypanozoon parasite derived from
T. brucei lineage, is mainly found in Africa, Asia and South America
though naturally, this parasite can infect almost all warm-blooded
animals with the exception of humans (Hoare, 1972; Brun et al.,
1998). Surra is a disease caused by T. evansi in animals, which
originally developed in camels in North Africa, but has since spread
through the Arabian Peninsula and Middle East toward China and
Southeast Asia, and has alsowas imported into Latin America by the
conquistadores (Desquesnes et al., 2013b). However, the ﬁrst well
documented T. evansi human infection case was observed in India
in 2005; it was investigated by the World Health Organization.
Production and hosting by Elsevunder a request of the Health Department of Maharashtra State
(Joshi et al., 2005; World Health Organization, 2005; Powar et al.,
2006). In this case, the patient was proved to produce an inefﬁ-
cient apolipoprotein-L1 (ApoL1) because of two genetic mutations
on each allele of the gene ApoL1 (Vanhollebeke et al., 2006). ApoL1
is considered as the key component of HDL in normal human serum
(NHS) for lysing animal trypanosomes; also called the trypanolytic
factor (Vanhamme et al., 2003). A number of similar cases were
reported in Southeast Asia (Desquesnes et al., 2013a). However, in a
recent case identiﬁed in Vietnam, a patient found infected by
T. evansi exhibited no immunosuppression and a normal ApoL1
level, which suggests that T. evansi may be a pathogen in humans
(Van Vinh Chau et al., 2016).
Trypanosoma lewisi is a worldwide Herpetosoma trypanosome
found in Rattus norvegicus, R. rattus and other related species such
as R. tanezumi (Milocco et al., 2012; Pumhom et al., 2014). Rats are
infected with T. lewisi mainly by ingestion of infected ﬂeas or byier B.V. This is an open access article under the CC BY-NC-ND license (http://
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et al., 2002). Trypanosoma lewisi has long been considered as a
rat-specific and non-pathogenic trypanosome to its natural hosts.
However, an increasing number of human cases of infection by
T. lewisi, with associated clinical signs, mainly fever, but also
coughing, edema, anemia and anorexia, have been reported in
some Asian countries such as India and Thailand (Johnson, 1933;
Shrivastava et al., 1974; Howie et al., 2006; Kaur et al., 2007;
Sarataphan et al., 2007; Banerjee et al., 2008; Verma et al., 2011).
These reports suggested that T. lewisimight be a neglected zoonotic
pathogen (Lun et al., 2009). Recent studies on the activity of human
serum demonstrated that T. lewisi is resistant to NHS, which con-
ﬁrms its potential as a human pathogen (Lun et al., 2015). In
addition, further studies have indicated that T. lewisi infection could
induce an immunosuppressive effect on its hosts, resulting in
increasing susceptibility to other pathogens, such as Salmonella
typhimurium, Cryptococcus neoformans and Toxoplasma gondii
(Nielsen et al., 1978; Catarinella et al., 1998; Gross et al., 2006;
Carrera et al., 2009). Consequently, more attention should be paid
to this cosmopolitan parasite.
Trypanosoma evansi is widely distributed in South China and
thousands of animals (mainly water buffalos) are still infected by
this parasite (Lun et al., 1993), while T. lewisi is also widely
distributed in most provinces of China (Liu and Liu, 1990; Lun et al.,
2015). In addition, a review of these atypical human cases was
recently published (Truc et al., 2013), to make a point of these rare
human infections.
Due to the wide distribution of these two animal trypanosomes,
occasionally infecting humans, and exhibiting a pathogenic po-
tential, it was necessary to conduct and evaluate serological
screenings in an “exposed” human population, particularly those
from the countryside in the endemic regions.
Materials and methods
Human data and samples
Blood samples were collected from 622 volunteers by medically
trained staff from Zhengzhou, Henan (Central China) and by health
examination for those seeking working permission in Zhaoqing,
Guangdong province, South China. Wet smears of the blood were
made to detect trypanosomes using microscopy. Serum samples
were separated using centrifugation and kept in Eppendorf tubes
at 80 C until laboratory tests were performed. Based on the
medical records, most of the persons grew up in villages around
25e250 km from towns or cities. Seventy-three percent of persons
from Guangdong had an experience of close contact with water
buffalo when they grew up in their hometown, while those from
Henan had experienced close contact with cattle; however, Henan
province is not an enzootic region of T. evansi (Lun et al., 1993). Most
of the persons from the South and Center mentioned that they had
experienced close contact with wild rats when they grew up in
their hometowns.
The present protocol was properly reviewed and approved by
the Ethical Committee of the School of Life Sciences, Sun Yat-Sen
University, Guangzhou, China.
Rat serum samples
Three Sprague-Dawley (SD) rats were infected using intraperi-
toneal injection with 1  106 T. lewisi (COP02) after thawing the
injectant from liquid nitrogen conservation. Two months after
infection, serum samples were collected from the infected rats for
the positive control. Serum samples of non-infected SD rats (n ¼ 3)
were used as the negative control. All serum samples were keptfrozen at 80 C until used in the enzyme-linked immunosorbent
assay (ELISA).
Serological tests for detection of antibodies directed against T.
evansi: card agglutination test for Trypanosomosis/Trypanosoma
evansi
The card agglutination test for Trypanosomosis/Trypanosoma
evansi (CATT/T. evansi; antigen lot No.12C3B2-2) was carried out on
sera diluted 1:4 as described by the manufacturer (Prince Leopold
Institute of Tropical Medicine; Belgium) and according to Bajyana
Songa et al. (1987 & 1988). Interpretation of the results is based
on visual appreciation of the agglutination, according to a reference
picture included in the commercial protocol leaﬂet; it results in
negative (), doubtful (±), or positive results (þ, þþ or þþþ).
Negative and positive reference samples are provided with the kit,
in order to validate the quality of reagents.
Serological tests for detection of antibodies directed against T.
lewisi: enzyme-linked immunosorbent assay Trypanosoma lewisi
All serum samples were tested for T. lewisi-speciﬁc antibody
using ELISA currently under development, according to a protocol
described below.
A sample of Trypanosoma lewisi (Wery L307 24/9/68) was pu-
riﬁed from the blood of the rats experimentally infected with
T. lewisi (Dethoua et al., 2013) using anion exchange chromatog-
raphy using DEAE cellulose. These live parasites were washed in
medium (Ringer Lactate; glucose 0.6%, KCl 0.4%, NaHCO3 0.125%,
polymixin B 5 mg/mL, L-glutamine 2 mM, MEM non-essential
amino acids, pH 8.0) according to Holzmuller et al. (2008). Para-
sites were added to eachwell (4 105/well) of a microplate (NUNC-
Immuno™ MicroWell™ 96 well solid plates; Sigma-Aldrich,
France) as previously described (Williams et al., 1996). The plates
were emptied and ﬁlled with phosphate-buffered saline (PBS)
containing 0.05% Tween 20, 10% glycerol and 1% bovine serum al-
bumin for 3 h at room temperature for blocking, washed twice with
PBS 0.05% Tween and air dried. Plates were wrapped in aluminum
paper for shipping from France to China. When received at the Sun
Yat-Sen University, Guangzhou, China, the plates were kept
at 20 C less than 8 mth. Before use, plates were placed at room
temperature for 1 h.
In the absence of human reference serum samples available
against T. lewisi, rat serum samples were used from T. lewisi-
infected and non-infected SD rats as positive and negative controls,
respectively. The secondary antibodies used for these samples were
rabbit anti-rat IgG (this conjugate was shown not to react with
human IgG; Boster; China). For human samples, the secondary
antibodies were rabbit anti-human IgG (this conjugate was shown
not to react with themouse or rat IgG; Boster; China). Sera collected
from infected SD rats 2 mth after infection with T. lewisi were used
as the positive control, while those from non-infected SD rats were
used as the negative control.
The ELISA procedurewas carried out by diluting 200 mL of serum
sample at 1:100 in PBS (containing 0.05% Tween 20, 5% glycerol and
2% BSA) which was added to each well, and the plates were incu-
bated for 2 h at room temperature. The plates were then washed,
and 200 mL of HRP conjugated detection antibody solution (sec-
ondary antibodies diluted in PBS containing 0.05% Tween 20 and 2%
BSA) were added. After incubation for 40 min at room temperature
and washing, color was developed by the addition of a substrate
solution containing tetramethylbenzidine chromogenic substrate
and stopped by the addition of 50 mL of stop solution to each well.
The optical densities (ODs) were measured at 450 nm in a micro-
plate reader. Each serum sample was run in triplicate. Validation of
Fig. 1. Serological response to Trypanosoma lewisi antigens in humans from Henan and
Guangdong, in Central and South China, respectively, where the ratio method was used
to describe positive or negative serum samples based on optical density (OD) and the
relative absorption ratio ¼ (ODSample - ODBlank)/(ODNegative - ODBlank).
Fig. 2. Frequency distribution of optical density (OD) values of all human samples from
Henan and Guangdong (using Statistical Package for Social Sciences (SPSS) version
13.0; SPSS Inc.; USA).
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negative (NC ¼ negative control) and positive reference samples
(PC ¼ positive control), expected to exhibit low and high optical
densities, respectively, using anti-rat conjugate.
Interpretation of the results for human samples: this ELISA be-
ing under development, and in the absence of positive reference
human samples, there was no cut off line available, so the inter-
pretation of the test was made as follows. When the relative ab-
sorption ratio of a sample, described as (ODSample - ODBlank)/
(ODNegative control - ODBlank), was greater than 2, it was arbitrarily
determined that this serum sample was highly suspect. Interme-
diary values, between 1.6 and 2, were also explored as doubtful
results.
Ethics statements
The present protocol was properly reviewed and approved by
the Ethical Committee of the School of Life Sciences, Sun Yat-Sen
University, Guangzhou, China.
Results
Serological tests for T. evansi infection: card agglutination test for
trypanosomosis//Trypanosoma evansi
Following the kit instructions, negative and positive reference
samples provided in the CATT/T. evansi kit gave expected results, as
positive reference samples produced strong agglutination, while
negative reference samples did not show any visible agglutination.
Visible agglutination was not observed in any of the 622 human
serum samples tested, and thus they were all considered negative
using the CATT/T. evansi.
Serological test for T. lewisi infection: enzyme-linked
immunosorbent assay of T. lewisi
The rat reference samples and the pool of 622 human serum
samples were examined for the anti-T. lewisi antibody using ELISA.
The positive and negative reference serum samples of the SD rats
proved to react as expected, with optical densities of PC ¼ 3.476,
NC ¼ 0.921. For human samples, the relative absorption ratio
(ODSample - ODBlank)/(ODNegative control - ODBlank) of three samples
was greater than 2.000, with a mean of 2.086. In samples from
Guangdong, the mean relative absorption ratio was 2.018, while
that of samples from Henan was 2.372.
From the total of 622 serum samples, as shown in Fig. 1, the
three samples (0.48%) exhibiting a relative absorption ratio > 2.000
were considered as “strongly suspect” samples. Exploring lower
rates, ﬁve samples (0.80%) exhibited a relative absorption ratio of
1.800e2.000, which were considered as “medium suspects” and
seven samples (1.13%) exhibited a relative absorption ratio of
1.600e1.800, which were considered as “low suspects”. In this
study, seroprevalence could not be obtained since the ELISA has not
yet been standardized; however three samples were strong sus-
pects and another 12 were considered as “suspects”, making a total
of 2.4%. The frequency distribution of the optical densities is pre-
sented in Fig. 2; the mean response in these 622 samples was op-
tical density 1.332 ± 0.367.
The serological response to T. lewisi antigens detected in
Guangdong province was slightly higher than that found in Henan
province (all samples with relative absorption ratio greater than 1.6
were included; 2.59% versus 2.27%, p ¼ 0.797; Table 1). However,
statistical analyses using a chi square test showed that these dif-
ferences were not signiﬁcant. In addition, the serological response
to T. lewisi antigens in females was higher than in males (total,3.23% versus 1.42%, p ¼ 0.145; Henan, 3.02% versus 1.31%, p ¼ 0.287
and Guangdong, 3.52% versus 1.56%, p¼ 0.312); however, statistical
analyses using a chi square test showed that these differences were
not signiﬁcant.
Discussion
Trypanosoma evansi and T. lewisi are worldwide-distributed
animal heamoﬂagellates, so both of them can be found in the
study area.
Trypanosoma evansi
Amongst mammals, Trypanosoma evansi has long been consid-
ered as pathogenic to animals only; humans were considered as
resistant, due to the trypanolytic factor present in the serum,
whereas animals may have sub-clinical expression, mild or strong
clinical signs up to death but including abortion, anemia, loss of
production (Hoare, 1972; Lun et al., 1993). Without appropriate
treatment for horses and dogs, it usually causes death. However,
the cases reported in India (Verma et al., 2011), as well as a recent
Table 1
Serological response to Trypanosoma lewisi antigens in humans from Henan and Guangdong, China.
Sampling site Number of tested samples Number of suspect samples Seroprevalence (%)
All Male Female All Male Female All Male Female
Henan 352 153 199 >2.0 1 0 1 0.28% 0 0.50%
1.8e2.0 3 1 2 1.96% 0.65% 1.00%
1.6e1.8 4 1 3 1.14% 0.65% 1.51%
>1.6 8 2 6 2.27% 1.31% 3.02%
Guangdong 270 128 142 >2.0 2 0 2 0.74% 0 1.41%
1.8e2.0 2 1 1 0.74% 0.78% 0.70%
1.6e1.8 3 1 2 1.11% 0.78% 1.41%
>1.6 7 2 5 2.59% 1.56% 3.52%
Total 622 281 341 >1.6 15 4 11 2.41% 1.42% 3.23%
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Vinh Chau et al., 2016), conﬁrm the ability of T. evansi to infect
humans with signiﬁcant clinical signs. The cases of T. evansi infec-
tion in humans caused a shock regarding public health since this
species is largely distributed and thus a large human population
may be exposed to infection. In terms of potential pathogenicity,
T. evansi being a species close to pathogens of African sleeping
sickness (World Health Organization, 2005), strong and possibly
fatal effects may be expected. In the ﬁrst fully documented case
observed in India, the patient exhibited a lack of efﬁcient ApoL-1
which explained the infection (Vanhollebeke et al., 2006).
T. evansi in such a case, is not sensitive to the lysis by a non-efﬁcient
ApoL-1; however, in the recent case described in Vietnam, gene
sequence and seric concentration of ApoL-1 were normal (Van Vinh
Chau et al., 2016), suggesting a real potential as a human pathogen.
In 2005, a serological surveywas conducted using CATT/T. evansi
in the residential area of the Indian patient of 2004. Out of 1806
individuals tested with CATT/T. evansi, 81 were positive using plain
serum. No trypanosome was detected in the blood of the 60 per-
sons positive to the test at a signiﬁcant serum dilution (minimum
1:4). These results may suggest a frequent human exposure to
T. evansi in the study area and, maybe a frequent transmission of
parasites to humans leading in a “normal” immune population to
transient infections. The speciﬁcity of the CATT/T. evansi test has not
been previously evaluated for human screening and was used in
this study for the ﬁrst time in Asia (Shegokar et al., 2006).
The absence of a CATT-positive result in the current study might
have been because there was no chance to collect serum samples
from the farmers taking care of buffaloes. Indeed, farmers are in
very close contact with their animals and could be considered as an
“exposed population”. On the other hand, the negative result from
the samples collected fromHenan province was expected since this
province is not an endemic region of T. evansi (Lun et al., 1993). As a
matter of fact, the serum samples collected from Henan province
were originally planned for the detection of T. lewisi infection and
were used for the negative control for T. evansi infection. It would
be very useful to work on the human T. evansi infection by estab-
lishing collaboration with the local CDC in China in order to survey
surely exposed populations.
Our results showed the absence of contact between the parasite
and the human population investigated. However, CATT/T. evansi
can mainly detect multivalent immunoglobulins such as IgMwhich
have a pentameric structure; consequently, it may be positive only
in case of recent circulation of the parasite in the blood. Thus, for
nonrecent contact, such a test would remain negative. To increase
the accuracy of such investigations, it might be advisable to use
both CATT/T. evansi and IgG detection ELISA/T. evansi in the future.
However, regarding the ELISA method, it is necessary to obtain
reference positive samples from human patients who have been
duly identiﬁed.Trypanosoma lewisi
Trypanosoma lewisi is considered as a non-pathogenic species
for its natural host of rats (Hoare, 1972). However, clinical signs
were reported in humans, mainly fever. The increasing number of
cases of T. lewisi infection in humans has drawn the attention of
international organizations such as the World Health Organization
(Truc et al., 2013). Trypanosoma lewisi can cause clinical signs in
infants and young patients (see reviews by Lun et al., 2009; Truc
et al., 2013), and its presence in the vicinity of human habitats
was recently shown to be quite high in Southeast Asia (Pumhom
et al., 2015). Importantly, unlike T. evansi which can be lysed by
normal human serum, T. lewisi is naturally resistant to such lysis
(Lun et al., 2015); thus it can naturally infect humans. Therefore,
T. lewisi has been considered as a potential zoonotic trypanosome
(Lun et al., 2015). Moreover, when evaluating the efﬁcacy of try-
panocides against T. lewisi, although initial work showed the efﬁ-
cacy of fexinidazole and pentamidine (Dethoua et al., 2013), other
workers demonstrated that all human and animal trypanocides
were inefﬁcient against this parasite in laboratory rats, including
fexinidazole and pentamidine (Desquesnes et al., 2016a, 2016b).
In the present study, out of the 622 human serum samples
collected from South and Central parts of China, 0.48e2.41% of the
samples reacted with T. lewisi antigens (using cut-off values of 2.0
OD and 1.6 OD, respectively). The three-highest seropositive sam-
ples were from females 27e29 years old, who had grown up in the
countryside before they left home as adults to work in the city;
more accurate epidemiological information was not available. If
these samples are considered as true positives, the results from the
present study indicate that although a low seroprevalence of
T. lewisi antibodies was found, contact between humans and
T. lewisi antigens or live T. lewisi can exist, leading to an immune
response and probably to transient or undetected infections or
both. Such results would support the conclusion of Liu and Liu
(1990) who reported a seroprevalence of 0.96% (15/1564 based on
ELISA) using hemagglutination and an agar diffusion test for
T. lewisi infection in human serum samples from Jilin province
(Northeast China).
More work, particularly more serum samples from populations
in the countryside of different regions, will be greatly beneﬁcial to
understanding T. lewisi infection in the Chinese population. In
addition, the environmental status of the residents should be
carefully investigated in future epidemiological surveys.
Trypanosomes of the lewisi group express and secrete receptors
for the immunoglobulins Fc region (Balber and Sturtevant, 1986;
Vincendeau and Da€eron, 1989). This nonspeciﬁc binding, inde-
pendent of an antigen-antibody reaction, has to be taken into ac-
count in serological assays. This indicates the needs to optimize and
develop reliable ELISA T. lewisi to improve the investigations on
T. lewisi infections in humans. To standardize such an ELISA test, it is
J.-M. Gao et al. / Agriculture and Natural Resources 52 (2018) 612e616616necessary to get positive reference human serum samples from
active infection cases.
Detection of active human infections by T. evansi or T. lewisi is
necessary to generate andmake available positive reference human
samples. This requires surveillance, which would be supported by
extensive distribution of the e-leaﬂet recently released by the
Network on Atypical Human Infections by Animal Trypanosomes
(NAHIAT) and that is available on the web.
More case reports will certainly help to develop diagnostic tools
and to improve the surveillance of atypical human infections by
animal trypanosomes.
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